Eating disorder
Conditions
Interventions
Participants will engage in the body-oriented intervention “Arousal Regulation”, which consists of eight weekly individual sessions of 60 minutes led by a (psychomotor) therapist experienced in workin
Sponsors
GGNet
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Patients are eligible for inclusion in the study if they meet all of the following criteria:Participation in inpatient eating disorder treatment.A current diagnosis of AN according to DSM-5 criteria. AN will be diagnosed by a licensed psychologist during an intake assessment by using the SCID-5-S interview.A comorbid diagnosis of PTSD according to DSM-5 criteria. PTSD will be assessed by a licensed psychologist during the intake assessment by using the SCID-5-S interview. Age 18 years and above.Demonstrated willingness to participate, confirmed by signing written informed consent.
Exclusion criteria
Exclusion criteria: Patients will be excluded from the study if they meet any of the following criteria:Current psychotic or manic episode.Severe substance use disorder (moderate or severe, based on DSM-5 criteria) that could interfere with treatment participation.Acute suicidality or self-harming behaviour requiring immediate crisis intervention or a higher level of care.Significant cognitive impairment or intellectual disability that would impede comprehension of the intervention or participation in assessments.Insufficient proficiency in Dutch, preventing adequate participation in treatment and study procedures.Medical instability or acute physical health problems that contraindicate participation in psychological treatment.Participation in another clinical trial that could interfere with the outcomes or procedures of the current study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary study outcome, feasibility, will be assessed on the five domains of 1) acceptability (Client Satisfaction Questionnaire (CSQ-8)); 2) demand (rate of participant enrolment); 3) implementation (drop-out, adherence and treatment integrity); 4) adaptation (Tops and Tips); and 5) preliminary efficacy (Multidimensional Assessment of Interoceptive Awareness – Version 2 (MAIA-2), Difficulties in Emotion Regulation Scale (DERS), Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5)). | — |
Countries
Netherlands
Contacts
Public ContactSHW Mares
GGNet
Outcome results
None listed